GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » Price-to-Free-Cash-Flow

PHVS (Pharvaris NV) Price-to-Free-Cash-Flow : N/A (As of Apr. 13, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV Price-to-Free-Cash-Flow?

As of today (2025-04-13), Pharvaris NV's share price is $12.00. Pharvaris NV's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.41. Hence, Pharvaris NV's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Pharvaris NV's Price-to-Free-Cash-Flow or its related term are showing as below:

PHVS's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 28.78
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Pharvaris NV's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.68. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-2.41.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -12.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -54.20% per year.

During the past 8 years, Pharvaris NV's highest 3-Year average Free Cash Flow per Share Growth Rate was -12.10% per year. The lowest was -128.10% per year. And the median was -77.15% per year.


Pharvaris NV Price-to-Free-Cash-Flow Historical Data

The historical data trend for Pharvaris NV's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV Price-to-Free-Cash-Flow Chart

Pharvaris NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Pharvaris NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharvaris NV's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Pharvaris NV's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharvaris NV's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharvaris NV's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pharvaris NV's Price-to-Free-Cash-Flow falls into.


;
;

Pharvaris NV Price-to-Free-Cash-Flow Calculation

Pharvaris NV's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12.00/-2.409
=N/A

Pharvaris NV's Share Price of today is $12.00.
Pharvaris NV's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.41.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Pharvaris NV  (NAS:PHVS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Pharvaris NV Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharvaris NV Business Description

Traded in Other Exchanges
Address
Emmy Noetherweg 2, Leiden, NLD, 2333 BK
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.